| ACE2 | Angiotensin-converting enzyme 2 |
| ACTH | Adrenocorticotropic Hormone |
| AII | Angiotensin II |
| AgRP | Agouti-related protein |
| AT1R | Angiotensin type 1a receptor |
| AVP | Arginine vasopressin |
| BBB | Blood brain barrier |
| BCSFB | Blood cerebrospinal fluid barrier |
| CART | Cocaine and amphetamine-regulated transcript |
| CCK | Cholecystokinin |
| CH | Caudal hypothalamus |
| CNS | Central nervous system |
| COVID-19 | Coronavirus disease 2019 |
| CRH | Corticotrophin releasing hormone |
| DNH | Dorsomedial hypothalamus |
| GCs | Glucocorticoids |
| GLP-1 | Glucagon-like peptide-1 |
| IL-1β | Interleukin 1β |
| IR | Insulin receptor |
| LHA | Lateral hypothalamic area |
| ME | Median eminence |
| MCH | Melanin-concentrating hormone |
| MSH | Melanocyte-stimulating hormones |
| NA | Nucleus ambiguus |
| NTS | Nucleus of the solitary tract |
| NPY | Neuropeptide |
| ObRb | Leptin receptor |
| OT | Oxytocin |
| PFA | Perifornical area |
| PNS | Peripheral nervous system |
| POMC | Pro-opiomelanocortin |
| PVN | Paraventricular nucleus |
| PYY | Polypeptide |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| TNFα | Tumor necrosis factor alpha |
| TRH | Thyrotropin-releasing hormone |
| VLM | Ventrolateral medulla |